Skip to main content
. 2018 Dec 14;3(3):351–358. doi: 10.1007/s41669-018-0110-3
Based on this case study, we recommend that the search for real-world evidence is initiated prior to submission of technologies to health technology assessment authorities.
A willingness to provide reassurance on outcomes with future data collection may reduce delays in new therapy reimbursement.